Skip to main content

Table 3 Prevalence of somatic, psychological and urogenital symptoms and of anxiety/depression and OR (95% CI) for its association with menopausal status

From: How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

 

Somatic symptoms

Psychological symptoms

Urogenital symptoms

Anxiety/depression

 

Crude

Adjusteda

 

Crude

Adjusteda

 

Crude

Adjusteda

 

Crude

Adjusteda

N (%)

OR [95% CI]

OR [95% CI]

N (%)

OR [95% CI]

OR [95% CI]

N (%)

OR [95% CI]

OR [95% CI]

N (%)

OR [95% CI]

OR [95% CI]

Pre-menopause (N = 44)

15 (34.1%)

1

1

18 (40.9%)

1

1

19 (43.2%)

1

1

5 (11.4%)

1

1

Peri-menopause (N = 70)

42 (60.0%)

2.90 [1.37–6.16]

3.01 [1.38–6.55]

38 (54.3%)

1.72 [0.71–4.16]

2.18 [0.87–5.40]

34 (48.6%)

1.24 [0.65–2.4]

1.09 [0.57–2.09]

13 (18.6%)

1.78 [0.69–4.60]

2.33 [0.69–7.85]

Post-menopause (N = 137)

80 (58.4%)

2.71 [1.57–4.69]

2.63 [1.44–4.81]

83 (60.6%)

2.22 [1.21–4.06]

2.16 [1.13–4.14]

86 (62.8%)

2.22 [1.26–3.90]

2.54 [1.42–4.85]

30 (21.9%)

2.19 [0.88–5.41]

1.66 [0.48–5.67]

p value

0.011

  

0.072

  

0.030

  

0.300

  
  1. Bold values are statistically significant
  2. OR: Odds Ratio from logistic regression for the association between menopausal status at the presence of menopausal symptoms in each MRS domain and of anxiety/depression
  3. aAdjusted for mode of transmission, current occupational status, smoking, drug use, social support, current partner